Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 210

1.

Vitamin D-gene interactions in multiple sclerosis.

Berlanga-Taylor AJ, Disanto G, Ebers GC, Ramagopalan SV.

J Neurol Sci. 2011 Dec 15;311(1-2):32-6. doi: 10.1016/j.jns.2011.08.041. Epub 2011 Oct 13. Review.

PMID:
22000399
2.

Multiple sclerosis, osteoporosis, and vitamin D.

Sioka C, Kyritsis AP, Fotopoulos A.

J Neurol Sci. 2009 Dec 15;287(1-2):1-6. doi: 10.1016/j.jns.2009.09.012. Epub 2009 Oct 2. Review.

PMID:
19800081
3.

Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians.

Orton SM, Ramagopalan SV, Para AE, Lincoln MR, Handunnetthi L, Chao MJ, Morahan J, Morrison KM, Sadovnick AD, Ebers GC.

J Neurol Sci. 2011 Jun 15;305(1-2):116-20. doi: 10.1016/j.jns.2011.02.032. Epub 2011 Mar 26.

PMID:
21440908
4.

Genetic aspects of vitamin D receptor and metabolism in relation to the risk of multiple sclerosis.

Krizova L, Kollar B, Jezova D, Turcani P.

Gen Physiol Biophys. 2013 Dec;32(4):459-66. doi: 10.4149/gpb_2013067. Epub 2013 Sep 26. Review.

PMID:
24067280
5.

Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis.

Smolders J, Damoiseaux J, Menheere P, Tervaert JW, Hupperts R.

J Neuroimmunol. 2009 Feb 15;207(1-2):117-21. doi: 10.1016/j.jneuroim.2008.12.011.

PMID:
19178954
6.

The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis.

Smolders J, Peelen E, Thewissen M, Menheere P, Tervaert JW, Hupperts R, Damoiseaux J.

Autoimmun Rev. 2009 Jun;8(7):621-6. doi: 10.1016/j.autrev.2009.02.009. Epub 2009 Feb 11. Review.

PMID:
19393206
7.

Vitamin D as an immune modulator in multiple sclerosis, a review.

Smolders J, Damoiseaux J, Menheere P, Hupperts R.

J Neuroimmunol. 2008 Feb;194(1-2):7-17. doi: 10.1016/j.jneuroim.2007.11.014. Epub 2008 Jan 4. Review.

PMID:
18177949
8.

Molecular network of chromatin immunoprecipitation followed by deep sequencing-based vitamin D receptor target genes.

Satoh J, Tabunoki H.

Mult Scler. 2013 Jul;19(8):1035-45. doi: 10.1177/1352458512471873. Epub 2013 Feb 11.

PMID:
23401126
9.

Predisposition to vitamin D deficiency osteomalacia and rickets in females is linked to their 25(OH)D and calcium intake rather than vitamin D receptor gene polymorphism.

Ray D, Goswami R, Gupta N, Tomar N, Singh N, Sreenivas V.

Clin Endocrinol (Oxf). 2009 Sep;71(3):334-40. doi: 10.1111/j.1365-2265.2008.03500.x.

PMID:
19094076
10.

Association study on two vitamin D receptor gene polymorphisms and vitamin D metabolites in multiple sclerosis.

Smolders J, Damoiseaux J, Menheere P, Tervaert JW, Hupperts R.

Ann N Y Acad Sci. 2009 Sep;1173:515-20. doi: 10.1111/j.1749-6632.2009.04656.x.

PMID:
19758194
11.

Vitamin D signaling is modulated on multiple levels in health and disease.

Ebert R, Schütze N, Adamski J, Jakob F.

Mol Cell Endocrinol. 2006 Mar 27;248(1-2):149-59. Epub 2006 Jan 9. Review.

PMID:
16406653
12.

Vitamin D receptor (VDR) gene SNPs influence VDR expression and modulate protection from multiple sclerosis in HLA-DRB1*15-positive individuals.

Agliardi C, Guerini FR, Saresella M, Caputo D, Leone MA, Zanzottera M, Bolognesi E, Marventano I, Barizzone N, Fasano ME, Al-Daghri N, Clerici M.

Brain Behav Immun. 2011 Oct;25(7):1460-7. doi: 10.1016/j.bbi.2011.05.015. Epub 2011 Jun 12.

PMID:
21664963
13.

Potential association of vitamin D receptor polymorphism Taq1 with multiple sclerosis.

Cox MB, Ban M, Bowden NA, Baker A, Scott RJ, Lechner-Scott J.

Mult Scler. 2012 Jan;18(1):16-22. doi: 10.1177/1352458511415562. Epub 2011 Aug 3.

PMID:
21816760
14.

The vitamin D hormone and its nuclear receptor: molecular actions and disease states.

Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK.

J Endocrinol. 1997 Sep;154 Suppl:S57-73. Review.

15.

Genetic variants in vitamin D metabolism-related genes and body mass index: analysis of genome-wide scan data of approximately 7000 Chinese women.

Dorjgochoo T, Shi J, Gao YT, Long J, Delahanty R, Xiang YB, Cai Q, Shu XO.

Int J Obes (Lond). 2012 Sep;36(9):1252-5. doi: 10.1038/ijo.2011.246. Epub 2011 Dec 13.

16.

Vitamin D in autoimmune liver disease.

Smyk DS, Orfanidou T, Invernizzi P, Bogdanos DP, Lenzi M.

Clin Res Hepatol Gastroenterol. 2013 Nov;37(5):535-45. doi: 10.1016/j.clinre.2013.05.016. Epub 2013 Jul 8. Review.

PMID:
23845396
17.

Genomic binding sites and biological effects of the vitamin D--VDR complex in multiple sclerosis [corrected].

Kalman B, Toldy E.

Neuromolecular Med. 2014 Jun;16(2):265-79. doi: 10.1007/s12017-014-8301-2. Epub 2014 Apr 8. Review. Erratum in: Neuromolecular Med. 2014 Sep;16(3):643.

PMID:
24711208
18.
19.

Immunomodulatory effects of Vitamin D in multiple sclerosis.

Correale J, Ysrraelit MC, Gaitán MI.

Brain. 2009 May;132(Pt 5):1146-60. doi: 10.1093/brain/awp033. Epub 2009 Mar 24.

PMID:
19321461
20.

The Association of Vitamin D Receptor Polymorphisms with Multiple Sclerosis in a Case-Control Study from Kuwait.

Al-Temaimi RA, Al-Enezi A, Al-Serri A, Alroughani R, Al-Mulla F.

PLoS One. 2015 Nov 5;10(11):e0142265. doi: 10.1371/journal.pone.0142265. eCollection 2015. Erratum in: PLoS One. 2015;10(12):e0144565. Al-Roughani, Raed [corrected to Alroughani, Raed].

Supplemental Content

Support Center